Researchers at Chalmers University of Technology in Sweden and the University of Auckland in New Zealand have developed a ...

Maryland surgeons perform groundbreaking transorbital surgery to remove spinal tumors through a patient's eye socket, saving a young woman with rare chordoma cancer.

During demyelination, lipid-rich myelin debris is released in the central nervous system (CNS) and must be phagocytosed and processed before new myelin can form. Although myelin comprises over 70% ...

This new model, in contrast, recapitulates the development of all three sections of embryonic brain and spinal cord simultaneously—something that has not been achieved in previous models.

An intelligent suit is hoped to significantly improve rehabilitation after a serious spinal cord injury. The AI-supported solution will be developed over the next three years by researchers from ...

The spinal cord is a column of nerve tissue that connects the brain to the rest of the body in vertebrate animals. Nerve cells in the spinal cord, called neurons, help to control and coordinate the ...

During development, the switch from a proliferative to a neurogenic division depends at least in part on changes in the relative length of the different phases of the cell cycle (Cheffer et al, 2013; ...

Transverse Impact on the Spinal Cord-Pia Mater Complex. Transverse impact on the SCP complex was simulated by replicating ex-vivo experimental tests on bovine spinal cord-pia mater specimens. The test ...

My name is Chris Ricketts, and last year, I experienced a life changing spinal injury. ... Adjusting to life with a spinal cord injury. ... so I tried to role model the person I’d like them to see.

Introduction. It is estimated that between 1/4 to 1/2 million people will endure a spinal cord injury (SCI) each year, world-wide (World Health Organization and International Spinal Cord Society, 2013 ...

Nusinersen is an antisense oligonucleotide drug that modifies pre-mRNA splicing of SMN2 to promote increased production of full-length SMN protein. 11 In a phase 2, open-label, dose-escalation ...